These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 11685380

  • 61. Claustral Neurons Projecting to Frontal Cortex Mediate Contextual Association of Reward.
    Terem A, Gonzales BJ, Peretz-Rivlin N, Ashwal-Fluss R, Bleistein N, Del Mar Reus-Garcia M, Mukherjee D, Groysman M, Citri A.
    Curr Biol; 2020 Sep 21; 30(18):3522-3532.e6. PubMed ID: 32707061
    [Abstract] [Full Text] [Related]

  • 62. Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.
    Maurice T, Martin-Fardon R, Romieu P, Matsumoto RR.
    Neurosci Biobehav Rev; 2002 Jun 21; 26(4):499-527. PubMed ID: 12204195
    [Abstract] [Full Text] [Related]

  • 63. Cocaine produces conditioned place aversion in mice with a cocaine-insensitive dopamine transporter.
    O'Neill B, Tilley MR, Gu HH.
    Genes Brain Behav; 2013 Feb 21; 12(1):34-8. PubMed ID: 23083326
    [Abstract] [Full Text] [Related]

  • 64. Effects of polyunsaturated fatty acids on cocaine-conditioned place preference in mice.
    Eserian JK, D'Almeida V, Andersen ML, Galduróz JC.
    Nutr Neurosci; 2012 Jul 21; 15(4):171-5. PubMed ID: 22390908
    [Abstract] [Full Text] [Related]

  • 65. The effect of ginseng extract on locomotor sensitization and conditioned place preference induced by methamphetamine and cocaine in mice.
    Tokuyama S, Takahashi M, Kaneto H.
    Pharmacol Biochem Behav; 1996 Aug 21; 54(4):671-6. PubMed ID: 8853188
    [Abstract] [Full Text] [Related]

  • 66. Inhibition by ginsenosides Rb1 and Rg1 of methamphetamine-induced hyperactivity, conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.
    Kim HS, Hong YT, Oh KW, Seong YH, Rheu HM, Cho DH, Oh S, Park WK, Jang CG.
    Gen Pharmacol; 1998 May 21; 30(5):783-9. PubMed ID: 9559335
    [Abstract] [Full Text] [Related]

  • 67. 5-HT1A autoreceptor in dorsal raphe nucleus mediates sensitization of conditioned place preference to cocaine in mice experienced with chronic pain.
    Li Y, Zhu J, Zheng Q, Qian Z, Zhang L, Wei C, Han J, Liu Z, Ren W.
    Neuroreport; 2019 Jun 12; 30(9):681-687. PubMed ID: 31045847
    [Abstract] [Full Text] [Related]

  • 68. Fluoxetine exposure during adolescence increases preference for cocaine in adulthood.
    Iñiguez SD, Riggs LM, Nieto SJ, Wright KN, Zamora NN, Cruz B, Zavala AR, Robison AJ, Mazei-Robison MS.
    Sci Rep; 2015 Oct 09; 5():15009. PubMed ID: 26449406
    [Abstract] [Full Text] [Related]

  • 69. Multidimensional Top-Down Proteomics of Brain-Region-Specific Mouse Brain Proteoforms Responsive to Cocaine and Estradiol.
    Park HM, Satta R, Davis RG, Goo YA, LeDuc RD, Fellers RT, Greer JB, Romanova EV, Rubakhin SS, Tai R, Thomas PM, Sweedler JV, Kelleher NL, Patrie SM, Lasek AW.
    J Proteome Res; 2019 Nov 01; 18(11):3999-4012. PubMed ID: 31550894
    [Abstract] [Full Text] [Related]

  • 70. Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice.
    Mori T, Ito S, Kita T, Sawaguchi T.
    J Pharmacol Sci; 2004 Dec 01; 96(4):459-64. PubMed ID: 15599099
    [Abstract] [Full Text] [Related]

  • 71. Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.
    Vouga A, Gregg RA, Haidery M, Ramnath A, Al-Hassani HK, Tallarida CS, Grizzanti D, Raffa RB, Smith GR, Reitz AB, Rawls SM.
    Neuropharmacology; 2015 Apr 01; 91():109-16. PubMed ID: 25496724
    [Abstract] [Full Text] [Related]

  • 72. Estradiol: a key biological substrate mediating the response to cocaine in female rats.
    Segarra AC, Agosto-Rivera JL, Febo M, Lugo-Escobar N, Menéndez-Delmestre R, Puig-Ramos A, Torres-Diaz YM.
    Horm Behav; 2010 Jun 01; 58(1):33-43. PubMed ID: 20026119
    [Abstract] [Full Text] [Related]

  • 73. Abuse liability of the dietary supplement dimethylamylamine.
    Dolan SB, Gatch MB.
    Drug Alcohol Depend; 2015 Jan 01; 146():97-102. PubMed ID: 25481853
    [Abstract] [Full Text] [Related]

  • 74. The role of serotonin in the actions of psychostimulants: molecular and pharmacological analyses.
    Cunningham KA, Bradberry CW, Chang AS, Reith ME.
    Behav Brain Res; 1996 Jan 01; 73(1-2):93-102. PubMed ID: 8788484
    [Abstract] [Full Text] [Related]

  • 75. Cocaine modifies brain lipidome in mice.
    Lin Y, Gu H, Jiang L, Xu W, Liu C, Li Y, Qian X, Li D, Li Z, Hu J, Zhang H, Guo W, Zhao Y, Cen X.
    Mol Cell Neurosci; 2017 Dec 01; 85():29-44. PubMed ID: 28830718
    [Abstract] [Full Text] [Related]

  • 76. Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice.
    Mediouni S, Jablonski J, Paris JJ, Clementz MA, Thenin-Houssier S, McLaughlin JP, Valente ST.
    Curr HIV Res; 2015 Dec 01; 13(1):64-79. PubMed ID: 25613133
    [Abstract] [Full Text] [Related]

  • 77. Dopamine mechanisms and cocaine reward.
    Ikegami A, Duvauchelle CL.
    Int Rev Neurobiol; 2004 Dec 01; 62():45-94. PubMed ID: 15530568
    [No Abstract] [Full Text] [Related]

  • 78. Evaluation of a pharmacokinetic hypothesis for reduced locomotor stimulation from methamphetamine and cocaine in adolescent versus adult male C57BL/6J mice.
    Zombeck JA, Gupta T, Rhodes JS.
    Psychopharmacology (Berl); 2009 Jan 01; 201(4):589-99. PubMed ID: 18797848
    [Abstract] [Full Text] [Related]

  • 79. Embryonic "binge" cocaine exposure alters neural-immune and neural-endocrine interactions in young chickens: involvement of serotonin(2) receptors.
    Schrott LM, Sparber SB.
    Brain Res Dev Brain Res; 2001 Sep 23; 130(1):99-107. PubMed ID: 11557098
    [Abstract] [Full Text] [Related]

  • 80. SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice.
    Hammond HR, Eans SO, Cirino TJ, Ananthan S, Jimenez-Torres AC, Zhu J, McLaughlin JP.
    NeuroImmune Pharm Ther; 2024 Mar 25; 3(1):1-6. PubMed ID: 38711842
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.